Total Aβ42/Aβ40 Ratio in Plasma Predicts Amyloid-Pet Status, Independent of Clinical AD Diagnosis

Neurology - United States
doi 10.1212/wnl.0000000000009240
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

The Demographic and Medical Correlates of Plasma Aβ40 and Aβ42

Alzheimer Disease and Associated Disorders
PsychiatryClinical PsychologyGerontologyGeriatricsMental Health
2013English

Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-Β Peptides Aβ40 and Aβ42

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Guinea Pig Ascorbate Status Predicts Tetrahydrobiopterin Plasma Concentration and Oxidation Ratio in Vivo

Nutrition Research
EndocrinologyNutritionMetabolismDieteticsDiabetes
2013English

Comparative Studies of Disordered Proteins With Similar Sequences: Application to Aβ40 and Aβ42

Biophysical Journal
Biophysics
2013English

Beta-Amyloid PET Imaging for Alzheimer's Dementia Diagnosis

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2018English

Results of BACE1-Inhibitor Clinical Trials Confirm Key Predictions for App-Independent Generation of Beta-Amyloid in Sporadic AD

2018English

Clinical, FDG and Amyloid PET Imaging in Posterior Cortical Atrophy

Journal of Neurology
Neurology
2015English

Varied Probability of Staying Collapsed/Extended at the Conformational Equilibrium of Monomeric Aβ40 and Aβ42

Scientific Reports
Multidisciplinary
2015English

Molecular Targets in the Rational Design of AD Specific PET Tracers: Tau or Amyloid Aggregates?

Current Alzheimer Research
Neurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy